| http://www.w3.org/ns/prov#value | - The invention is based on transgenic non-human animals expressing the AMPK ??3 subunit and their use as a model for diseases relating to energy metabolism, including obesity, dyslipidemia, insulin resistance syndrome, and type 2 diabetes.
|
